Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513182 · ClinicalTrials.gov registry record · NA
Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?
A NA study of Cutibacterium Acnes, sponsored by University of Utah.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06513182: Active NA study of Cutibacterium Acnes, sponsored by University of Utah.
NCT06513182 is a NA study of Cutibacterium Acnes that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06513182, a NA study of Cutibacterium Acnes, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Prosthetic joint infection is a devastating complication of shoulder arthroplasty. A relatively novel method of preventing PJI has been with the use of a wound protection device. There is minimal investigative research on the use of a wound protector in shoulder arthroplasty, specifically with an ability to decrease wound contamination. The investigators primary purpose of the proposed study is to determine if the use of a wound protector deceases the deep wound colonization of bacteria in primary shoulder arthroplasty. A secondary purpose is to evaluate if the wound protector decreases soft tissue trauma during total shoulder arthroplasty.
Primary Outcome
The primary outcome of the study will be percent of positive C acnes culture results.
Conditions Studied
Interventions
- OTHER No Alexis orthopaedic protector
- DEVICE Alexis orthopaedic protector
Study Locations (1)
Utah
- University of Utah Orthopedics - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-06-21 |
| Est. Completion | 2029-06 |
| Phase | NA |
What the registry record for NCT06513182 still lists
NCT06513182 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Cutibacterium Acnes appearing as the primary indexed condition, and to 2 interventions - of which No Alexis orthopaedic protector is the first listed.
NCT06513182 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06513182 about?
NCT06513182 is a clinical study titled "Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?". Prosthetic joint infection is a devastating complication of shoulder arthroplasty. A relatively novel method of preventing PJI has been with the use of a wound protection device. There is minimal investigative research on the use of a wound protector in shoulder arthroplasty, specifically with an ab...
What is the current status of trial NCT06513182?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-06-21. Estimated completion is 2029-06.
What conditions does trial NCT06513182 study?
This clinical trial studies the following conditions: Cutibacterium Acnes.
What interventions are being tested in trial NCT06513182?
The interventions under investigation include: No Alexis orthopaedic protector (OTHER), Alexis orthopaedic protector (DEVICE).
Who is sponsoring clinical trial NCT06513182?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513182 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutibacterium Acnes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06513182's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI